Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419M Buy
3,264,106
+27,533
+0.9% +$3.22M 0.62% 25
2026
Q1
$389M Buy
3,236,573
+349,219
+12% +$40.3M 0.65% 21
2025
Q4
$304M Buy
2,887,354
+115,048
+4% +$10.8M 0.51% 26
2025
Q3
$233M Buy
2,772,306
+88,567
+3% +$7.29M 0.42% 35
2025
Q2
$212M Buy
2,683,739
+137,112
+5% +$10.9M 0.44% 35
2025
Q1
$229M Buy
2,546,627
+346,109
+16% +$32.3M 0.55% 30
2024
Q4
$219M Sell
2,200,518
-73,633
-3% -$7.59M 0.57% 27
2024
Q3
$258M Buy
2,274,151
+55,275
+2% +$6.57M 0.67% 25
2024
Q2
$275M Buy
2,218,876
+329,933
+17% +$42.5M 0.76% 21
2024
Q1
$249M Buy
1,888,943
+118,970
+7% +$14.7M 0.82% 17
2023
Q4
$193M Sell
1,769,973
-19,963
-1% -$2.07M 0.69% 22
2023
Q3
$184M Sell
1,789,936
-76,285
-4% -$8.22M 0.78% 20
2023
Q2
$215M Buy
1,866,221
+447,732
+32% +$50.8M 0.88% 13
2023
Q1
$151M Sell
1,418,489
-121,804
-8% -$13.2M 0.68% 12
2022
Q4
$171M Buy
1,540,293
+203,155
+15% +$20.8M 0.84% 11
2022
Q3
$115M Sell
1,337,138
-133,497
-9% -$11.9M 0.66% 14
2022
Q2
$134M Sell
1,470,635
-70,733
-5% -$6.27M 0.71% 15
2022
Q1
$126M Sell
1,541,368
-569,304
-27% -$44.9M 0.63% 22
2021
Q4
$162M Buy
2,110,672
+213,185
+11% +$17M 0.68% 23
2021
Q3
$143M Sell
1,897,487
-59,832
-3% -$4.55M 0.64% 27
2021
Q2
$152M Sell
1,957,319
-49,969
-2% -$3.72M 0.67% 24
2021
Q1
$148M Sell
2,007,288
-259,766
-11% -$19.2M 0.72% 25
2020
Q4
$177M Sell
2,267,054
-117,110
-5% -$8.96M 0.92% 15
2020
Q3
$189M Sell
2,384,164
-32,261
-1% -$2.53M 1.11% 13
2020
Q2
$178M Buy
2,416,425
+661,748
+38% +$49.8M 1.11% 12
2020
Q1
$129M Buy
1,754,677
+42,369
+2% +$3.33M 0.94% 14
2019
Q4
$149M Buy
1,712,308
+89,127
+5% +$7.32M 0.9% 18
2019
Q3
$130M Buy
1,623,181
+267,449
+20% +$21.4M 0.88% 19
2019
Q2
$108M Sell
1,355,732
-39,802
-3% -$3.05M 0.75% 25
2019
Q1
$111M Sell
1,395,534
-65,479
-4% -$4.9M 0.74% 23
2018
Q4
$107M Sell
1,461,013
-386,618
-21% -$27.3M 0.79% 25
2018
Q3
$125M Sell
1,847,631
-118,806
-6% -$7.57M 0.69% 26
2018
Q2
$114M Sell
1,966,437
-69,950
-3% -$3.95M 0.67% 29
2018
Q1
$106M Sell
2,036,387
-138,832
-6% -$7.5M 0.65% 33
2017
Q4
$117M Sell
2,175,219
-118,774
-5% -$6.58M 0.66% 34
2017
Q3
$140M Buy
2,293,993
+40,918
+2% +$2.48M 0.75% 25
2017
Q2
$138M Buy
2,253,075
+143,295
+7% +$8.72M 0.77% 23
2017
Q1
$128M Sell
2,109,780
-61,342
-3% -$3.72M 0.73% 25
2016
Q4
$122M Buy
2,171,122
+92,328
+4% +$5.4M 0.73% 24
2016
Q3
$124M Buy
2,078,794
+75,591
+4% +$4.42M 0.77% 24
2016
Q2
$110M Sell
2,003,203
-102,333
-5% -$5.45M 0.75% 24
2016
Q1
$106M Buy
2,105,536
+38,532
+2% +$1.89M 0.79% 23
2015
Q4
$104M Buy
2,067,004
+298,303
+17% +$15M 0.79% 23
2015
Q3
$83.4M Sell
1,768,701
-106,439
-6% -$5.65M 0.69% 27
2015
Q2
$102M Sell
1,875,140
-122,934
-6% -$6.89M 0.72% 25
2015
Q1
$110M Buy
1,998,074
+314,788
+19% +$17.8M 0.75% 22
2014
Q4
$91.2M Buy
1,683,286
+107,882
+7% +$6.01M 0.71% 26
2014
Q3
$89.1M Sell
1,575,404
-27,141
-2% -$1.52M 0.71% 27
2014
Q2
$88.5M Buy
1,602,545
+21,592
+1% +$1.18M 0.68% 25
2014
Q1
$85.6M Sell
1,580,953
-189,843
-11% -$9.83M 0.69% 22
2013
Q4
$84.6M Buy
1,770,796
+209,315
+13% +$9.57M 0.71% 26
2013
Q3
$70.9M Buy
1,561,481
+191,280
+14% +$8.73M 0.62% 31
2013
Q2
$60.7M Buy
+1,370,201
New +$61.2M 0.61% 36

Other funds holding MRK

Aviva's MRK Position: Q2 2026 in Review

Aviva increased its Merck (MRK) stake by 0.85% in Q2 2026, buying an estimated $3.22M and bringing the position to 3,264,106 shares worth $419M. The position accounts for 0.62% of the portfolio, ranked #25.

Aviva first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aviva held 3,264,106 shares of Merck worth $419M as of Q2 2026.
  • Aviva bought 27,533 Merck shares in Q2 2026, an estimated $3.22M.
  • Merck made up 0.62% of Aviva's portfolio in Q2 2026, its #25 holding.
  • Aviva first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.